Discordant Amyloid Status Diagnosis in Alzheimer's Disease.
Lorena García-VallésCarmen Peña-BautistaLourdes Álvarez-SánchezInés Ferrer-CairolsMiguel BaqueroConsuelo Cháfer-PericásPublished in: Biomedicines (2022)
In common clinical practice at tertiary memory centers, result discrepancies between tests of amyloid status are far more common than expected. However, episodic memory tests remain an important support method for AD diagnosis, especially in cases with discrepant results between amyloid PET and CSF biomarkers.